Daniil Gataulin Stock Analyst Profile - Chardan Capital Research Coverage - Stocknear

Daniil Gataulin

Stock Analyst at Chardan Capital

(5)
# 110
Out of 5,506 analysts
124
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

21 Stocks

Name Action PT Current % Upside Ratings Updated
OCUL Ocular Therapeutix
Maintains: Buy
21 21
11.41 84.05% 2 Oct 2, 2025
ZURA Zura Bio
Maintains: Buy
10 10
3.93 154.45% 2 Sep 30, 2025
QURE uniQure
Maintains: Strong Buy
35 76
54.92 38.38% 8 Sep 25, 2025
OCGN Ocugen
Maintains: Buy
7 7
1.77 295.48% 14 Sep 19, 2025
TRML Tourmaline Bio
Downgrades: Neutral
70 48
47.9 0.21% 4 Sep 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
52 52
10.43 398.56% 13 Sep 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
3 3
1.06 183.02% 10 Aug 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
61 61
15.49 293.8% 6 Aug 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 35
8.45 314.2% 5 Aug 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
33 33
5.39 512.24% 8 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 15
8.7 72.41% 7 Aug 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 4
1.55 158.06% 8 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 27
13.73 96.65% 12 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Jul 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
28 33
17.57 87.82% 7 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 4
n/a n/a 4 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
220 220
0.59 37188.14% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
22 13
n/a n/a 2 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
n/a n/a 2 Sep 28, 2022